ストックスクリーナーアプリを入手
11.10
3.23%
-0.37
Enanta Pharmaceuticals Inc (ENTA) 最新ニュース
Enanta Pharmaceuticals stock fell 2.78 percent on October 5 - AD HOC NEWS
Enanta Pharmaceuticals Inc (9EP.SG) Analyst insights, Price targets and Recommendations - Yahoo Finance Australia
Enanta Pharmaceuticals stock gains 4.48 percent to EUR 11.65 - AD HOC NEWS
Layoff Tracker: Merck adds 53 jobs to New Jersey chopping block - BioSpace
How Enanta Pharmaceuticals Inc. (ENTA) Affects Rotational Strategy Timing - Stock Traders Daily
How Enanta Pharmaceuticals Inc. (ENTA) Affects Rotational Strategy Timing - Stock Traders Daily
Enanta Pharmaceuticals to Participate in September Investor Conferences - Moomoo
Enanta Pharmaceuticals stock falls 1.25 percent to USD 11.85 - AD HOC NEWS
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
ENTA Reiterated by HC Wainwright & Co. -- Price Target Maintained at $20 - GuruFocus
Enanta Pharmaceuticals stock rating reiterated at Buy by H.C. Wainwright - Investing.com Canada
Enanta Pharmaceuticals stock trades at USD 12.11 - AD HOC NEWS
Enanta Pharmaceuticals reports new STAT6 inhibitors - BioWorld News
Enanta Pharmaceuticals reports new STAT6 inhibitors - bioworld.com
The One-Carbon Mistake That Cost A Patent Its Priority Date - marketscreener.com
(ENTA) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
ENTA stock holds steady as Enanta Pharmaceuticals focuses on antiviral pipeline - AD HOC NEWS
Enanta Pharmaceuticals stock gains after new SEC filing and solid cash position - AD HOC NEWS
Enanta Pharmaceuticals to Participate in September Investor Conferences - finance.yahoo.com
Enanta stock holds in the low teens as investors look to recent trial and earnings progress - ad-hoc-news.de
Enanta Pharmaceuticals to Participate in September Investor Conferences - Business Wire
Enanta (ENTA) Watch: Finishes 2.59% Up at $13.47 for the Current Session; Boundary Watch: the Price Remains Bounded by the Supplied Support and ResistanceMoney Flow Index - vinanet.vn
Deep Track Capital, LP Trims Enanta Pharmaceuticals Inc (ENTA) S - GuruFocus
Enanta Pharmaceuticals Announces Q3 Fiscal 2026 Financial Results - Kalkine Media
Enanta Pharmaceuticals Inc (NASDAQ: ENTA) Share Price, ENTA Stock News, ENTA Share Price & Updates - Kalkine
Enanta Pharmaceuticals Inc (NASDAQ: ENTA) Share Price, ENTA Stock News, ENTA Share Price & Updates - kalkine.ca
H.C. Wainwright Maintains Enanta Pharmaceuticals(ENTA.US) With Buy Rating, Maintains Target Price $20 - Moomoo
Enanta Pharma reports $19.5 million Q3 loss, advances RSV pipeline - scanx.trade
Enanta Pharmaceuticals (ENTA) Reports Q3 Loss, Lags Revenue Estimates - NewsBreak: Local News & Alerts
Enanta Pharmaceuticals (ENTA) Reports Q3 Loss, Lags Revenue Estimates - Yahoo Finance
Is Enanta Pharmaceuticals (ENTA) Overvalued After Q3 Earnings Mi - GuruFocus
Enanta Pharmaceuticals Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Enanta Pharma misses Q3 estimates on lower royalty revenue By Investing.com - Investing.com Canada
Enanta Pharma misses Q3 estimates on lower royalty revenue By Investing.com - Investing.com South Africa
Enanta Fiscal Q3 2026 Earnings: Higher Royalty-Related Interest Expense Widens Net Loss - TradingKey
Enanta Pharma misses Q3 estimates on lower royalty revenue - Investing.com
Enanta Pharmaceuticals (NASDAQ:ENTA) Posts Earnings Results, Misses Expectations By $0.16 EPS - marketbeat.com
Enanta Pharmaceuticals reports Q3 loss; revenue $14.4M, cash and securities $211.5M - tradingview.com
Enanta Pharma On Track to File IND for EPS-3903, an Oral, Once-Daily STAT6 Inhibitor and to Select MRGPRX2 Development Candidate, in 2H >ENTA - Moomoo
Enanta Pharmaceuticals: Fiscal Q3 Earnings Snapshot - Barchart.com
Enanta Pharmaceuticals: Fiscal Q3 Earnings Snapshot - KTVB
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter Ended June 30, 2026 - Business Wire
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter Ended June 30, 2026 - finance.yahoo.com
Enanta Pharmaceuticals Inc expected to post a loss of 51 cents a shareEarnings Preview - TradingView
Enanta Pharmaceuticals (ENTA) Climbs 3.2% as Shares Test Key Resistance at $14.46Call Dominated - vinanet.vn
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
(ENTA) Risk Channels and Responsive Allocation - Stock Traders Daily
Enanta Pharmaceuticals (ENTA) Expected to Post Quarterly Earnings on Monday - MarketBeat
Enanta Pharmaceuticals Inc (ENTA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
ENTA|Enanta Pharmaceuticals Inc|Price:12.780|Chg%:-0.170 - TradingKey
4.22%
大文字化:
|
ボリューム (24 時間):